That must be really old news because I can't find it anywhere. The point is a drug needs to have activity for multiple indications to be profitable these days. Here is another promising candidate which may compete with Onyx's compound:
http://www.sciencedaily.com/releases/2007/10/071024183049.htm
one of the best buying opportunities, page-9
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
